Illumina Inc. logo

ILMN

Illumina Inc.

$217.18

Earnings Summary

Revenue
$794Mn
Net Profits
$179Mn
Net Profit Margins
22.54%

Highlights

Revenue:

Illumina Inc.’s revenue fell -12.46% since last year same period to $794Mn in the Q3 2020. On a quarterly growth basis, Illumina Inc. has generated 25.43% jump in its revenue since last 3-months.

Net Profits:

Illumina Inc.’s net profit fell -23.5% since last year same period to $179Mn in the Q3 2020. On a quarterly growth basis, Illumina Inc. has generated 280.85% jump in its net profits since last 3-months.

Net Profit Margins:

Illumina Inc.’s net profit margin fell -12.62% since last year same period to 22.54% in the Q3 2020. On a quarterly growth basis, Illumina Inc. has generated 203.63% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Illumina Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.45
EPS Estimate Current Year
0.45

Highlights

EPS Estimate Current Quarter:

Illumina Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.45 - a 50% jump from last quarter’s estimates.

EPS Estimate Current Year:

Illumina Inc.’s earning per share (EPS) estimates for the current year stand at 0.45.

Key Ratios

Key ratios of the Illumina Inc. post its Q4 2022 earnings

Return on Assets (ROA)
0.01
Return on Equity (ROE)
-0.51

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Illumina Inc.’s return on assets (ROA) stands at 0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Illumina Inc.’s return on equity (ROE) stands at -0.51.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2019-07-31
1.34
1.35
0.75%
2019-10-25
1.4
1.93
37.86%
2020-02-11
1.58
1.7
7.59%
2019-04-26
1.34
1.6
19.4%

Company Information

Illumina is improving human health by unlocking the power of the genome. Its focus on innovation has established it as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.

Organisation
Illumina Inc.
Headquarters
5200 Illumina Way, San Diego, CA, United States, 92122
Employees
11500
Industry
Health Technology
CEO
Francis deSouza